The role of toll-like receptors in chronic B-cell malignancies.
about
Regulatory Role of IL-1R8 in Immunity and DiseaseIbrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLLExploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia.TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivoThe lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patientsDysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma.Decoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily.TLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosisToll-like Receptors in Chronic Lymphocytic Leukemia.Toll-like receptors targeting technology for the treatment of lymphoma.Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders.TIR8/SIGIRR is an Interleukin-1 Receptor/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and ImmunityOverexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice.Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8.B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors.The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia.
P2860
Q26752524-484CCCBB-2D0E-4CB5-B5AD-57D6D28E1879Q33714712-CC6ED37A-44F4-410B-B402-CF4E7DC2CD46Q34056568-79355E14-C1E7-451C-8127-33C5D1C0BD50Q34320769-9B4FFD8D-C1EE-479B-9212-A9C9D57A7213Q34542102-FA5CB5DD-1C7B-4456-9780-BA7B447A1A2CQ36476656-99DEE0E0-2431-4F5D-ACBA-760A34C28129Q36781293-44D10CE4-C1AF-447F-8F69-5E8FF89BDD62Q36994635-4E231EC8-9E65-49CA-8683-EEA7301A1BD1Q37185126-98BA29B8-7A83-4D24-A72B-4F81D3C74AF4Q38042942-135F2F2C-BEF8-49C7-A818-3A2CC328579BQ38948266-E4222F76-F1D6-46EE-BF3F-C27DA43228F3Q39477274-6F0D54B2-9E09-4D49-90C3-989BFC0DC3ECQ41677234-4BF0CFCB-30AA-41A1-919D-4FEB03162CCDQ41786115-6C657757-9DE9-42AE-9016-9472D58C5404Q47285918-93BB145D-F652-4D9E-B640-FBD01C7D4525Q50056654-61DABC89-25C7-44C1-94C2-D97123859DF4Q51104017-4302FD8D-2460-4AFA-9537-82AD053BC95B
P2860
The role of toll-like receptors in chronic B-cell malignancies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of toll-like receptors in chronic B-cell malignancies.
@en
The role of toll-like receptors in chronic B-cell malignancies.
@nl
type
label
The role of toll-like receptors in chronic B-cell malignancies.
@en
The role of toll-like receptors in chronic B-cell malignancies.
@nl
prefLabel
The role of toll-like receptors in chronic B-cell malignancies.
@en
The role of toll-like receptors in chronic B-cell malignancies.
@nl
P2093
P2860
P1433
P1476
The role of toll-like receptors in chronic B-cell malignancies.
@en
P2093
Federico Caligaris-Cappio
Maria T S Bertilaccio
Michela Frenquelli
P2860
P304
P356
10.1080/10428190903115410
P577
2009-10-01T00:00:00Z